It is likely that these isoforms compete with membrane-bound CD155 for DNAM-1 binding, decreasing DNAM-1-dependent cytotoxicity and facilitating tumor evasion from NK cell detection and elimination, as demonstrated in a murine melanoma model [63]. This evidence concerns the gene CD226 and melanoma.